Skip to content

Pharminent

cropped-ChatGPT-Image-May-28-2026-10_46_23-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Market Access
  • Medicare Advantage Out-of-Pocket Limits: Variation and Trends
  • Market Access

Medicare Advantage Out-of-Pocket Limits: Variation and Trends

KFF Medicare

This brief analyzes out-of-pocket limits in Medicare Advantage plans in 2026, variation by plan type, the distribution of enrollees facing different out-of-pocket limits, and trends over time.

Read full story

pharminent May 28, 2026 (Last updated: May 29, 2026)

KFF Medicare

This brief analyzes out-of-pocket limits in Medicare Advantage plans in 2026, variation by plan type, the distribution of enrollees facing different out-of-pocket limits, and trends over time.

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: GSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’
Next: Ahead of ASCO data drop, AZ gets key Imfinzi approval

Related Stories

  • Market Access

European study shows inequality in access to new medicines

pharminent May 19, 2026
  • Market Access

Deal finally unlocks NHS access to ITF’s Duchenne drug

pharminent May 11, 2026
  • Market Access

Specialty Pharmacy Accreditation: DCI’s Exclusive Analysis Reveals a Market at an Inflection Point

pharminent May 5, 2026

You May Have Missed

  • Clinical Data

ASCO: BMS hails “compelling” phase 3 celmod readout

pharminent May 29, 2026
  • Clinical Data

Summit’s PD-1/VEGF to take center stage at ASCO, with wide impact for peers

pharminent May 29, 2026
  • M&A / Deals

Pfizer bets up to $10.5B in 12-candidate cancer collab with China’s Innovent

pharminent May 29, 2026
  • Regulatory

Ahead of ASCO data drop, AZ gets key Imfinzi approval

pharminent May 29, 2026
Copyright © 2026 All rights reserved. | ReviewNews by AF themes.